SynthesisFrontiers in oncology2021

Association of Survival and Immune-Related Adverse Events With Anti-PD-1/PD-L1 and Anti-CTLA-4 Inhibitors, Alone or Their Combination for the Treatment of Cancer: A Systematic Review and Meta-Analysis of 13 Clinical Trials.

Leyin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.